Quetiapine Fumarate
Pricing Report NDC 0310-8282-60

Latest NADAC: $0.54603 per EA · Effective May 20, 2020 · Est. package price $32.76 (60 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Quetiapine Fumarate Extended Release (NDC 0310-8282-60) is $0.54603 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 20, 2020.

As a provided by Astrazeneca Pharmaceuticals Lp, this medication is distributed in a 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.54603
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
May 20, 2020
Billable Units
60 EA
Estimated Package Price
$32.76
Data Status
As of Jun 03, 2020
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0310-8282-60
Description
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2017, the NADAC wholesale price for (NDC ) has moved within a range of $0.43087 to $12.01235 per EA. Over this 2 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4309 - $12.0124
Market Volatility
2,687.93% Variance
Latest Trend
0.32%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
May 20, 2020 $0.54603 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2020 $0.54429 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2020 $0.53266 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2020 $0.48709 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2020 $0.60393 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2019 $0.47329 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2019 $0.52329 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2019 $0.61983 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2019 $0.55340 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2019 $0.53287 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 17, 2019 $0.49671 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2019 $0.55595 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026